Skip to main content
. 2018 May 3;18(1):279–291. doi: 10.3892/mmr.2018.8963

Figure 1.

Figure 1.

Kaplan-Meier survival analysis of RFS time for patients classified using the 5-long noncoding RNA signature-based risk scoring system in the (A) training set and the (B) testing set. Patients in the training set and the testing set are classified into L and H groups. H, high-risk; L, low-risk; RFS, recurrence-free survival.